Home › Free Stock Grades › PCRX
Pacira BioSciences, Inc. (PCRX) Stock Grade
PCRX · Healthcare
A
Market Cap
$998.7M
P/E Ratio
164.0
Revenue Growth (YoY)
+3.6%
Net Margin
1.0%
Return on Equity
1.0%
Dividend Yield
None
About Pacira BioSciences, Inc.'s fundamentals
Pacira BioSciences is a specialty pharmaceutical company with a market capitalization of $998.7 million and modest revenue growth of 3.6% year-over-year, indicating limited expansion in its core business. The company operates with an extremely thin net margin of 1.0%, meaning only a penny of profit is generated per dollar of revenue, while its return on equity stands at 1.0%, suggesting inefficient use of shareholder capital. With a P/E ratio of 164.0, the stock is priced at a significant multiple relative to current earnings, and the company does not pay a dividend to shareholders.